executive vice presidentÂ
Teva Pharmaceutical Industires
Israel
Kåre Schultz (21 May 1961) is a Danishbusiness executive. He was appointed to new chief executive officer of Teva Pharmaceutical Industries in September 2017.
Schultz has a Cand.polit. degree from the University of Copenhagen in 1987. He initially worked as a consultant for Andersen Consulting in London and for McKinsey in Copenhagen.